ReviewJournal of medicinal chemistry2009

Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Rongshi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.